MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Automated pattern based classification in neuropathology proven parkinsonism

    K. Schindlbeck, D. Gupta, C. Tang, S. O'Shea, K. Poston, V. Dhawan, J.P Vonsattel, S. Fahn, D. Eidelberg (New York, NY, USA)

    Objective: In patients with parkinsonism and uncertain differential diagnosis, an automated image-based algorithm can help to distinguish idiopathic Parkinson’s disease (IPD) from atypical parkinsonian syndromes…
  • MDS Virtual Congress 2020

    A reliable measure of rigidity with a novel robotic device

    L. Caranzano, J. Madrid, F. Feurestein, T. Nef, D. Benninger (Lausanne, Switzerland)

    Objective: The objective of our study was to objectively measure the rigidity in PD patients, using a recently validated robotic device. Background: Rigidity is one…
  • MDS Virtual Congress 2020

    Excessive Daytime Sleepiness in Parkinson’s disease and Narcolepsy Genetic Risk Allele HLA DQB1*0602

    S. Azher, E. Molho, A. Hahn, O. Adam (Albany, NY, USA)

    Objective: To determine whether narcolepsy risk allele HLA DQB1*0602 is associated with excessive daytime sleepiness (EDS) in patients with Parkinson's disease (PD) on dopaminergic agents.…
  • MDS Virtual Congress 2020

    The Clinical Heterogeneity of Orthostatic Hypotension in PD Patients

    P.Z Li, LL. Peng, J.L Wang, Y.M Liu (Jinan, China)

    Objective: The objects of the research were to investigate the clinical heterogeneity of orthostatic hypotension(OH) in PD Patients, to explore the possible risk factors for…
  • MDS Virtual Congress 2020

    Dietary insights of Parkinson’s Disease patients

    N. Palavra, M. Lubomski, V. Flood, R. Davis, C. Sue (St Leonards, Australia)

    Objective: To report on the patterns of nutritional intake in an Australian Parkinson’s disease (PD) cohort. Background: There is limited information about the dietary habits…
  • MDS Virtual Congress 2020

    Insomnia may have a mediating role in linking Parkinson’s disease severity to depression and anxiety

    G. Yeganyan, S. Khachatryan, Z. Tavadyan (Yerevan, Armenia)

    Objective: The aim of this study was to investigate the role of insomnia in relationship of disease severity with depression/anxiety in patients with Parkinson’s disease…
  • MDS Virtual Congress 2020

    Prevalence, Impact, and Suboptimal Treatment of Depression in the Fox Insight Cohort

    R. Dobkin, M. Gara, S. Mann, K. Rodriguez, A. Interian (Piscataway, NJ, USA)

    Objective: Addressing unmet mental health needs in Parkinson’s disease (PD) requires delineating their scope and impact. This study evaluated (1) depressive symptom prevalence and treatment…
  • MDS Virtual Congress 2020

    Using mindfulness to improve self-awareness in Parkinson’s disease patients – preliminary results of a randomized controlled trial

    T. Buchwitz, F. Maier, A. Greuel, C. Eggers (Marburg, Germany)

    Objective: This clinical trial aims to investigate the effects and feasibility of a newly developed 8-week mindfulness intervention on self-awareness in Parkinson’s disease (PD) patients.…
  • MDS Virtual Congress 2020

    Apomorphine Sublingual Film for On-Demand Treatment of “OFF” Episodes in Patients With Parkinson’s Disease: Impact on Dyskinesia

    K. Klos, J. Hui, B. Robottom, P. Bhargava, B. Navia (Tulsa, OK, USA)

    Objective: Assess impact of apomorphine sublingual film (APL-130277; APL) on time spent with and functional impact of dyskinesia among patients with Parkinson’s disease (PD) and…
  • MDS Virtual Congress 2020

    Real Time Quality Control for Subjective Endpoints in Clinical Trials

    Y. Peng, G. Morinan, J. O'Keeffe (London, United Kingdom)

    Objective: Here we present a system which is capable of performing nearly-real time monitoring of UPDRS part-3 motor assessments using a combination of multidimensional statistics…
  • « Previous Page
  • 1
  • …
  • 76
  • 77
  • 78
  • 79
  • 80
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley